Different methods to analyze clinical experiments with multiple endpoints: a comparison of real data

Area of Science:

• Clinical Trials
• Biostatistics
• Drug Efficacy Evaluation

Background:

• Clinical experiments often involve multiple measurements for comprehensive results evaluation.
• Existing literature presents various methods to address challenges in analyzing multiple outcome measures.
• A key challenge is managing multiple testing bias, which can inflate significance.

Purpose of the Study:

• To review and compare statistical methods for handling multiple outcome measures in clinical trials.
• To evaluate different approaches for mitigating multiple testing bias.
• To assess the practical application of these methods using a real-world clinical trial dataset.

Main Methods:

• Literature review of statistical techniques for multiple outcome analysis.
• Comparative analysis of methods focusing on the most significant difference versus those utilizing all data.
• Application and comparison of selected methods to a clinical trial with 14 outcome measures.

Main Results:

• Different analytical methods yield varying results when applied to multiple outcome measures.
• Methods that incorporate all experimental data may offer a more comprehensive assessment of drug efficacy.
• The choice of method impacts the interpretation of statistical significance and drug effectiveness.

Conclusions:

• Selecting the appropriate statistical method is crucial for accurate interpretation of clinical trial results with multiple endpoints.
• Methods considering all available data can provide a more robust evaluation of drug efficacy.
• Further research into optimal methods for multiple outcome analysis is warranted.